Vanda’s Top Brass Quietly Unload a Wave of Shares in Coordinated Sell-Off
at www.tipranks.com (Wed, 4-Mar 9:07 PM)
Market Chameleon (Tue, 3-Mar 9:03 AM)
Vanda granted public hearing to review FDA denying Hetlioz for jet lag
at seekingalpha.com (Tue, 3-Mar 4:40 PM)
Vanda Pharmaceuticals: Limited Downside, Pipeline-Driven Upside Supports $24 Target Price
at www.tipranks.com (Mon, 2-Mar 6:36 AM)
Vanda Pharmaceuticals Sets Sights on 2026 Citizens Life Sciences Conference Participation
Market Chameleon (Fri, 27-Feb 8:56 AM)
Market Chameleon (Wed, 25-Feb 7:55 AM)
Market Chameleon (Mon, 23-Feb 9:54 AM)
Market Chameleon (Thu, 12-Feb 8:24 AM)
FDA Approves Vanda’s NEREUS—First Novel Motion Sickness Drug in 40 Years Spurs Historic Milestone
Market Chameleon (Wed, 31-Dec 9:53 AM)
Market Chameleon (Mon, 15-Dec 11:44 AM)
Market Chameleon (Mon, 15-Dec 8:37 AM)
FDA Clears Path for Vanda’s Tradipitant: Clinical Hold Lifted and PDUFA Decision Looms
Market Chameleon (Fri, 5-Dec 11:10 AM)
Market Chameleon (Fri, 5-Dec 8:39 AM)